Neurogenic detrusor overactivity in patients with spinal cord injury: Evaluation and management

Current Urology Reports

Volumn 12, Issue 6, 2011, Pages 404-412

  Sahai, Arun ^a   Cortes, Eduardo ^b   Seth, Jai ^c   Khan, Muhammad Shamim ^a   Panicker, Jalesh ^c   Kelleher, Cornelius ^b   Kessler, Thomas M ^d   Fowler, Clare J ^c   Dasgupta, Prokar ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Antimuscarinics; Botulinum toxin; Clam augmentation cystoplasty; Clean intermittent self catheterization; Conservative management; Detrusor myomectomy; Detrusor overactivity; Detrusor sphincter dyssynergia; Ileal conduit; Ileocystoplasty; Neurogenic detrusor overactivity; Neurostimulation; Overactive bladder; Sacral neuromodulation; Spinal cord injury; Spinal cord injury guideline; Urinary diversion

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIBIOTIC AGENT; BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; PLACEBO; TOLTERODINE; TRICYCLIC ANTIDEPRESSANT AGENT; TROSPIUM CHLORIDE;

ARTICLE; BLADDER CAPACITY; BLADDER EMPTYING; BLURRED VISION; CATHETER INFECTION; CONSERVATIVE TREATMENT; CONSTIPATION; DORSAL RHIZOTOMY; DRUG DOSE ESCALATION; DRUG MEGADOSE; DRY EYE; HUMAN; INDWELLING CATHETER; LOWER URINARY TRACT SYMPTOM; MONOTHERAPY; MUSCLE RESECTION; NERVE STIMULATION; NEUROGENIC BLADDER; NEUROMODULATION; OVERACTIVE BLADDER; PRACTICE GUIDELINE; SPINAL CORD INJURY; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION; URINE INCONTINENCE; URODYNAMICS; VENTRAL ROOT; XEROSTOMIA;

DISEASE MANAGEMENT; HUMANS; INCIDENCE; NEUROMUSCULAR AGENTS; NEUROTRANSMITTER AGENTS; PROGNOSIS; SPINAL CORD INJURIES; URINARY BLADDER, NEUROGENIC; URINATION; UROLOGIC SURGICAL PROCEDURES; WORLD HEALTH;

EID: 81355148763     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-011-0221-1     Document Type: Article

References (63)

1. M Horstmann T Schaefer Y Aguilar A Stenzl KD Sievert 2006 Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage Neurourol Urodyn. 25 5 441 5 16847942 10.1002/nau.20289 1:CAS:528:DC%2BD28XpsFGhs7c%3D
2. MJ DeVivo Y Chen ST Mennemeyer A Deutsch 2011 Topics in Spinal Cord Injury Rehabilitation. 16 4 1 9 10.1310/sci1604-1
3. Yue Cao YC, Michael J. DeVivo. Topics in Spinal Cord Injury Rehabilitation. 2011;16(4):10-6.
4. RH Hackler 1977 A 25-year prospective mortality study in the spinal cord injured patient: comparison with the long-term living paraplegic J Urol. 117 4 486 8 850323 1:STN:280:DyaE2s7ksVeqtQ%3D%3D (Pubitemid 8093952)
5. IB Lidal H Snekkevik G Aamodt N Hjeltnes F Biering-Sorensen JK Stanghelle 2007 Mortality after spinal cord injury in Norway J Rehabil Med. 39 2 145 51 17351697 10.2340/16501977-0017
6. P Abrams M Agarwal M Drake W El-Masri S Fulford S Reid, et al. 2008 A proposed guideline for the urological management of patients with spinal cord injury BJU Int. 101 8 989 94 18279449 10.1111/j.1464-410X.2008.07457.x This guideline was developed by doctors in the United Kingdom, experts in the urinary tract management of patients with spinal cord injury. (Pubitemid 351422564)
7. • J. Pannek MS, B. Blok, D. Castro-Diaz, G. Del Popolo, G. Kramer, P. Radziszewski, A. Reitz, J-J. Wyndaele. Guidelines on neurogenic lower urinary tract dysfunction. European Association of Urology. 2011. These are current guidelines on the management of various types of neurogenic lower urinary tract dysfunction.
8. WC de Groat N Yoshimura 2006 Mechanisms underlying the recovery of lower urinary tract function following spinal cord injury Prog Brain Res. 152 59 84 16198694 10.1016/S0079-6123(05)52005-3
9. •• de Groat WC, Yoshimura N. Plasticity in reflex pathways to the lower urinary tract following spinal cord injury. Exp Neurol. May 9. This is an excellent recent review from leaders in their field regarding the neurophysiology of micturition and changes that occur following spinal cord injury.
10. CJ Fowler D Griffiths WC de Groat 2008 The neural control of micturition Nat Rev Neurosci. 9 6 453 66 18490916 10.1038/nrn2401 1:CAS:528: DC%2BD1cXmtVahurc%3D (Pubitemid 351704950)
11. PC Wing 2008 Early acute management in adults with spinal cord injury: a clinical practice guideline for health-care providers. Who should read it? J Spinal Cord Med. 31 4 360 18959352
12. T Watanabe DA Rivas MB Chancellor 1996 Urodynamics of spinal cord injury Urol Clin North Am. 23 3 459 73 8701559 10.1016/S0094-0143(05)70325-6 1:STN:280:DyaK28zitlSktQ%3D%3D (Pubitemid 26260189)
13. SA Kaplan MB Chancellor JG Blaivas 1991 Bladder and sphincter behavior in patients with spinal cord lesions J Urol. 146 1 113 7 2056568 1:STN:280:DyaK3M3nvVWltA%3D%3D
14. EJ McGuire JR Woodside TA Borden RM Weiss 2002 Prognostic value of urodynamic testing in myelodysplastic patients. 1981 J Urol. 167 2 Pt 2 1049 53 11905876 10.1016/S0022-5347(02)80338-X discussion 54
15. AS Burns DA Rivas JF Ditunno 2001 The management of neurogenic bladder and sexual dysfunction after spinal cord injury Spine (Phila Pa 1976) 26 24 Suppl 129 36 10.1097/00007632-200112151-00022
16. JJ Wyndaele H Madersbacher A Kovindha 2001 Conservative treatment of the neuropathic bladder in spinal cord injured patients Spinal Cord. 39 6 294 300 11438850 10.1038/sj.sc.3101160 1:STN:280:DC%2BD3MzosFWgtA%3D%3D (Pubitemid 32624943)
17. RB Hansen F Biering-Sorensen JK Kristensen 2010 Urinary incontinence in spinal cord injured individuals 10-45 years after injury Spinal Cord. 48 1 27 33 19488052 10.1038/sc.2009.46 1:STN:280:DC%2BC3c%2FgvFWjtA%3D%3D
18. RB Hansen F Biering-Sorensen JK Kristensen 2004 Bladder emptying over a period of 10-45 years after a traumatic spinal cord injury Spinal Cord. 42 11 631 7 15326470 10.1038/sj.sc.3101637 1:STN:280:DC%2BD2crltFygsA%3D%3D (Pubitemid 39545954)
19. CJ Bennett MN Young RH Adkins F Diaz 1995 Comparison of bladder management complication outcomes in female spinal cord injury patients J Urol. 153 5 1458 60 7714965 10.1016/S0022-5347(01)67432-9 1:STN:280: DyaK2M3jtVOmsQ%3D%3D
20. AP Cameron LP Wallner DG Tate AV Sarma GM Rodriguez JQ Clemens 2010 Bladder management after spinal cord injury in the United States 1972 to 2005 J Urol. 184 1 213 7 20478597 10.1016/j.juro.2010.03.008
21. K Pettersson-Hammerstad O Jonsson IB Svennung AK Karlsson 2008 Impaired renal function in newly spinal cord injured patients improves in the chronic state-effect of clean intermittent catheterization? J Urol. 180 1 187 91 18499190 10.1016/j.juro.2008.03.051 discussion 91
22. S Vaidyanathan BM Soni G Singh T Oo PL Hughes 2011 Barriers to implementing intermittent catheterisation in spinal cord injury patients in Northwest Regional Spinal Injuries Centre, Southport, U.K. ScientificWorldJournal. 11 77 85 21218264 10.1100/tsw.2011.12
23. AP Cameron LP Wallner MB Forchheimer JQ Clemens RL Dunn G Rodriguez, et al. 2011 Medical and psychosocial complications associated with method of bladder management after traumatic spinal cord injury Arch Phys Med Rehabil. 92 3 449 56 21276958 10.1016/j.apmr.2010.06.028
24. CW Liu KH Attar A Gall J Shah M Craggs 2009 The relationship between bladder management and health-related quality of life in patients with spinal cord injury in the UK Spinal Cord. 48 4 319 24 19841636 10.1038/sc.2009.132
25. S Saint JG Elmore SD Sullivan SS Emerson TD Koepsell 1998 The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis Am J Med. 105 3 236 41 9753027 10.1016/S0002-9343(98)00240-X 1:STN:280:DyaK1cvitl2nuw%3D%3D (Pubitemid 28443213)
26. Desai DG, Liao KS, Cevallos ME, Trautner BW. Silver or nitrofurazone impregnation of urinary catheters has a minimal effect on uropathogen adherence. J Urol. 2010;184(6):2565-71.
27. Cardenas DD, Moore KN, Dannels-McClure A, Scelza WM, Graves DE, Brooks M, et al. Intermittent catheterization with a hydrophilic-coated catheter delays urinary tract infections in acute spinal cord injury: a prospective, randomized, multicenter trial. PM R. 2011 May;3(5):408-17.
28. Jahn P, Preuss M, Kernig A, Seifert-Huhmer A, Langer G. Types of indwelling urinary catheters for long-term bladder drainage in adults. Cochrane Database Syst Rev. 2007(3):CD004997.
29. Ryu KH, Kim YB, Yang SO, Lee JK, Jung TY. Results of urine culture and antimicrobial sensitivity tests according to the voiding method over 10 years in patients with spinal cord injury. Korean J Urol. 2011;52(5):345-9.
30. K Everaert N Lumen W Kerckhaert P Willaert M van Driel 2009 Urinary tract infections in spinal cord injury: prevention and treatment guidelines Acta Clin Belg 64 4 335 40 19810421 1:STN:280:DC%2BD1MnnsFOkuw%3D%3D
31. CR Chapple V Khullar Z Gabriel D Muston CE Bitoun D Weinstein 2008 The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis Eur Urol. 54 3 543 62 18599186 10.1016/j.eururo.2008.06.047 1:CAS:528:DC%2BD1cXhtFKisb%2FK
32. N Bennett M O'Leary AS Patel M Xavier JR Erickson MB Chancellor 2004 Can higher doses of oxybutynin improve efficacy in neurogenic bladder? J Urol. 171 2 Pt 1 749 51 14713802 10.1097/01.ju.0000103274.38694.b1 1:CAS:528: DC%2BD2cXisV2mtg%3D%3D (Pubitemid 38090473)
33. M O'Leary JR Erickson CP Smith C McDermott J Horton MB Chancellor 2003 Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injury J Spinal Cord Med 26 2 159 62 12828295 (Pubitemid 36834721)
34. B Amend J Hennenlotter T Schafer M Horstmann A Stenzl KD Sievert 2008 Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects Eur Urol. 53 5 1021 8 18243516 10.1016/j.eururo.2008.01.007 1:CAS:528:DC%2BD1cXns1ejtrk%3D This was a small study assessing combined antimuscarinic therapy in those who failed dose escalation with monotherapy. This approach resulted in successful treatment for 85% of patients.
35. MJ Kennelly GE Lemack JE Foote CS Trop 2009 Efficacy and safety of oxybutynin transdermal system in spinal cord injury patients with neurogenic detrusor overactivity and incontinence: an open-label, dose-titration study Urology. 74 4 741 5 19628264 10.1016/j.urology.2009.05.008
36. Natalin R, Reis LO, Alpendre C, Ikari LY, Prudente A, D'Ancona CA. Triple therapy in refractory detrusor overactivity: a preliminary study. World J Urol. 2010;28(1):79-85.
37. A Apostolidis P Dasgupta P Denys S Elneil CJ Fowler A Giannantoni, et al. 2009 Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report Eur Urol. 55 1 100 19 18823697 10.1016/j.eururo.2008.09.009 1:CAS:528:DC%2BD1MXhslOls7o%3D
38. I Ehren D Volz E Farrelly L Berglund L Brundin C Hultling, et al. 2007 Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity: a randomised, placebo-controlled, double-blind study Scand J Urol Nephrol. 41 4 335 40 17763227 10.1080/00365590601068835 1:CAS:528:DC%2BD2sXhtVSku7fN (Pubitemid 47357195)
39. B Schurch M de Seze P Denys E Chartier-Kastler F Haab K Everaert, et al. 2005 Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study J Urol. 174 1 196 200 15947626 10.1097/01.ju. 0000162035.73977.1c 1:CAS:528:DC%2BD2MXkvFSqtbg%3D This article provides evidence for the efficacy of botulinum toxin A in treating NDO from a phase 2 placebo-controlled randomized trial. (Pubitemid 40825713)
40. F Cruz J Heesakkers P Aliotta C Thompson W Lam G Daniell C Haag-Molkenteller 2011 Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity European Urology Supplements 10 2 190 10.1016/S1569-9056(11)60569-1
41. F Mascarenhas M Cocuzza CM Gomes N Leao 2008 Trigonal injection of botulinum toxin-A does not cause vesicoureteral reflux in neurogenic patients Neurourol Urodyn. 27 4 311 4 17914742 10.1002/nau.20515 1:CAS:528: DC%2BD1cXmsV2mt7c%3D (Pubitemid 351656402)
42. G Del Popolo MT Filocamo V Li Marzi A Macchiarella F Cecconi G Lombardi, et al. 2008 Neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre Eur Urol 53 5 1013 19 17950989 10.1016/j.eururo.2007.09.034 (Pubitemid 351434489)
43. C Dowson MS Khan P Dasgupta A Sahai 2010 Repeat botulinum toxin-A injections for treatment of adult detrusor overactivity Nat Rev Urol 7 12 661 7 21139642 10.1038/nrurol.2010.187 1:CAS:528:DC%2BC3cXhsFaqsLbM This review summarizes the efficacy and safety of repeated botulinum toxin injections for NDO.
44. A Sahai MS Khan P Dasgupta 2007 Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial J Urol. 177 6 2231 6 17509328 10.1016/j.juro.2007.01.130 1:CAS:528:DC%2BD2sXmslKlu7k%3D (Pubitemid 46726400)
45. TM Kessler S Khan J Panicker A Roosen S Elneil CJ Fowler 2009 Clean intermittent self-catheterization after botulinum neurotoxin type A injections: short-term effect on quality of life Obstet Gynecol. 113 5 1046 51 19384119
46. B Wefer B Ehlken J Bremer H Burgdorfer B Domurath C Hampel, et al. 2010 Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX) therapy in Germany World J Urol. 28 3 385 90 19693509 10.1007/s00345-009-0466-1
47. S Hori P Patki KH Attar S Ismail JC Vasconcelos PJ Shah 2009 Patients' perspective of botulinum toxin-A as a long-term treatment option for neurogenic detrusor overactivity secondary to spinal cord injury BJU Int. 104 2 216 20 19220255 10.1111/j.1464-410X.2009.08368.x
48. JM Vastenholt GJ Snoek HP Buschman HE van der Aa ER Alleman MJ Ijzerman 2003 A 7-year follow-up of sacral anterior root stimulation for bladder control in patients with a spinal cord injury: quality of life and users' experiences Spinal Cord. 41 7 397 402 12815371 10.1038/sj.sc.3101465 1:STN:280: DC%2BD3s3ovVaksg%3D%3D (Pubitemid 36819589)
49. PE Van Kerrebroeck EL Koldewijn PF Rosier H Wijkstra FM Debruyne 1996 Results of the treatment of neurogenic bladder dysfunction in spinal cord injury by sacral posterior root rhizotomy and anterior sacral root stimulation J Urol. 155 4 1378 81 8632580 10.1016/S0022-5347(01)66272-4 (Pubitemid 26081245)
50. J Kutzenberger B Domurath D Sauerwein 2005 Spastic bladder and spinal cord injury: seventeen years of experience with sacral deafferentation and implantation of an anterior root stimulator Artif Organs. 29 3 239 41 15725225 10.1111/j.1525-1594.2005.29043.x (Pubitemid 41648024)
51. M Hohenfellner J Pannek U Botel S Dahms J Pfitzenmaier J Fichtner, et al. 2001 Sacral bladder denervation for treatment of detrusor hyperreflexia and autonomic dysreflexia Urology. 58 1 28 32 11445474 10.1016/S0090-4295(01)01108-6 1:STN:280:DC%2BD3MzptFCktA%3D%3D (Pubitemid 32633930)
52. FM Martens PP den Hollander GJ Snoek EL Koldewijn PE van Kerrebroeck JP Heesakkers 2011 Quality of life in complete spinal cord injury patients with a Brindley bladder stimulator compared to a matched control group Neurourol Urodyn 30 4 551 5 21328472 10.1002/nau.21012 This cross-sectional study assessed QoL in patients using SARS compared to a matched controlled group.
53. • Kessler TM, La Framboise D, Trelle S, Fowler CJ, Kiss G, Pannek J, et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis. Eur Urol. 2010;58(6):865-74. This is a systematic review and meta-analysis of the efficacy and safety of neuromodulation for neurogenic lower urinary tract dysfunction, with a nice summary on potential mechanisms of action.
54. KD Sievert B Amend G Gakis P Toomey A Badke HP Kaps, et al. 2010 Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury Ann Neurol. 67 1 74 84 20186953 10.1002/ana.21814 This is a landmark study assessing the use of early neuromodulation during the AD phase of SCI. Results suggest that NDO and DSD can be prevented with this strategy.
55. Game XKT, Elneil S, Hamid R. Neurogenic bladder dysfunction: surgical interventional approaches. Pelvic Organ Dysfunction in Neurological Disease: Cambridge Medicine; 2010, p. 112-26.
56. PC Cartwright BW Snow 1989 Bladder autoaugmentation: early clinical experience J Urol. 142 2 Pt 2 505 8 2746767 1:STN:280:DyaL1MzhtFOisQ%3D%3D discussion 20-1 (Pubitemid 19193656)
57. M Stohrer G Kramer M Goepel D Lochner-Ernst D Kruse H Rubben 1997 Bladder autoaugmentation in adult patients with neurogenic voiding dysfunction Spinal Cord. 35 7 456 62 9232751 10.1038/sj.sc.3100441 1:STN:280:DyaK2szns1OhsQ%3D%3D (Pubitemid 27316466)
58. WW Leng HJ Blalock WH Fredriksson SF English EJ McGuire 1999 Enterocystoplasty or detrusor myectomy? Comparison of indications and outcomes for bladder augmentation J Urol. 161 3 758 63 10022679 10.1016/S0022-5347(01) 61761-0 1:STN:280:DyaK1M7ksFaktQ%3D%3D (Pubitemid 29422361)
59. TJ Greenwell SN Venn AR Mundy 2001 Augmentation cystoplasty BJU Int. 88 6 511 25 11678743 10.1046/j.1464-4096.2001.001206 1:STN:280: DC%2BD3MrntVKnsg%3D%3D (Pubitemid 34293790)
60. JL Chen HC Kuo 2009 Long-term outcomes of augmentation enterocystoplasty with an ileal segment in patients with spinal cord injury J Formos Med Assoc. 108 6 475 80 19515628 10.1016/S0929-6646(09)60095-4
61. EW Gerharz A Mansson S Hunt EC Skinner W Mansson 2005 Quality of life after cystectomy and urinary diversion: an evidence based analysis J Urol. 174 5 1729 36 16217273 10.1097/01.ju.0000176463.40530.05 (Pubitemid 41546923)
62. T Fazili TR Bhat S Masood JH Palmer GR Mufti 2006 Fate of the leftover bladder after supravesical urinary diversion for benign disease J Urol. 176 2 620 1 16813905 10.1016/j.juro.2006.03.056 (Pubitemid 43927932)
63. JN Cheng N Lawrentschuk D Gyomber J Rogerson DM Bolton 2010 Cystectomy in patients with spinal cord injury: indications and long-term outcomes J Urol. 184 1 92 8 20478600 10.1016/j.juro.2010.03.014